PK/PD modeling for AIDS: Where do we stand today?
PK models for antivirals are generally well-defined
Several good models of viral dynamics have been developed
For PIs and NNRTIs, plausible mechanistic relationships between drug concentrations in plasma and inhibition of viral replication have been proposed